Based in Tampa, Florida, Virginia Pelley is a former women's magazine editor who has written health and fitness content for Men's Journal, Cosmopolitan magazine, the Chicago Tribune, ...

Strattera (atomoxetine) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). Strattera comes as an oral capsule. Strattera is used in adults and certain ...

Strattera vs. Ritalin: What Is the Difference? Strattera and Ritalin are medicines that children and adults can take to manage symptoms of attention deficit hyperactivity disorder (ADHD). Both drugs ...

Strattera is a non-stimulant medication for ADHD that works by increasing norepinephrine in your brain. Common side effects of Strattera include dry mouth, nausea, and reduced appetite. Stimulants ...

Strattera, an attention deficit hyperactivity disorder treatment manufactured by Eli Lilly, will carry a "black box" warning based on a review of earlier clinical trials that found the drug might ...

The Food and Drug Administration warned doctors Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention deficit ...

Eli Lilly’s big-earning ADHD med Strattera has succumbed to generics. Four drugmakers won FDA green lights for their copycats Tuesday, and the competitive pressure is expected to quickly tank the ...

The Food and Drug Administration (FDA) is advising health care professionals about a new warning for Strattera, a drug approved for attention deficit hyperactivity disorder (ADHD) in adults and ...

Eli Lilly and Co., the world’s biggest maker of psychiatric drugs, convinced a judge to temporarily block generic versions of its attention-deficit treatment Strattera while the company considers an ...

Strattera had $483.3 million in sales in the first three quarters of fiscal year 2004. Anthony Butler, an analyst for Lehman Brothers, predicts sales of $770 million in FY 2005 (Wall Street Journal, ...

Eli Lilly & Co.’s Strattera faces generic competition after the drugmaker lost a U.S. court case over the attention-deficit treatment, its second patent ruling setback in a month. U.S. District Judge ...

For as long as she can remember, 29-year-old Vanessa Jaramillo has struggled to concentrate — a problem that affected her school years and later caused challenges at work. The dog groomer from Georgia ...